Search Login Register

Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) Summary

272 relevant articles (7 outcomes, 16 trials/studies) found for this Disease

Description: Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IMMUNOGLOBULIN G deposited at the dermo-epidermal junction.

Also Known As: Acquired Epidermolysis Bullosa; Epidermolysis Bullosa, Acquired

Key Drugs and Agents for Epidermolysis Bullosa Acquisita

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cyclosporine (Ciclosporin) : 2 outcomes in 14 results : FDA 20 Generic
  2. Intravenous Immunoglobulins (IVIG) : 2 outcomes in 6 results : FDA 1
  3. Collagen Type VII : 1 outcome 5 studies in 63 results : IBA
  4. Antibodies : 1 outcome 2 studies in 29 results : IBA
  5. Colchicine : 1 outcome in 5 results : FDA 9
  6. Monoclonal Antibodies : 1 outcome in 2 results : IBA
  7. Gb3 antigen : 1 outcome in 1 result : IBA
  8. Autoantibodies : 3 studies in 63 results : IBA
  9. Immunoglobulin G (IgG) : 3 studies in 49 results : IBA
  10. Antigens : 3 studies in 42 results : IBA
Show All >>

Diseases Related to Epidermolysis Bullosa Acquisita

  1. Lichen Planus (Lichen Ruber Planus)
  2. Atopic Dermatitis (Atopic Eczema)
  3. Pyoderma Gangrenosum
  4. Psoriasis (Pustulosis Palmaris et Plantaris)
  5. Glycogen Storage Disease Type VI (Glycogenosis Type VI)
Show All >>

Key Therapies for Epidermolysis Bullosa Acquisita

Efficacy Chart >>
  1. Photopheresis : 1 outcome in 2 results
  2. Lasers (Laser) : 3 results
  3. Tracheostomy : 2 results
  4. Plasma Exchange : 2 results
  5. Transplants (Transplant) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.